相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of 1H-NMR Spectroscopy and Gas Chromatography-Mass Spectrometry
Yarrow J. McConnell et al.
METABOLITES (2017)
Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer
Guopei Luo et al.
ANNALS OF SURGERY (2017)
Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites
Iole Maria Di Gangi et al.
Oncotarget (2016)
Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study
Hirofumi Akita et al.
PANCREAS (2016)
Omics-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives
Holly Matthews et al.
PROTEOMES (2016)
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
M. Ducreux et al.
ANNALS OF ONCOLOGY (2015)
Effects of processing and storage conditions on charged metabolomic profiles in blood
Akiyoshi Hirayama et al.
ELECTROPHORESIS (2015)
Plasma Metabolite Biomarkers for the Detection of Pancreatic Cancer
Guoxiang Xie et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Metabolic system alterations in pancreatic cancer patient serum: potential for early detection
Shawn A. Ritchie et al.
BMC CANCER (2013)
Erlotinib Prolongs Survival in Pancreatic Cancer by Blocking Gemcitabine-Induced MAPK Signals
Koji Miyabayashi et al.
CANCER RESEARCH (2013)
Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients
Mayuko Tsuruoka et al.
ELECTROPHORESIS (2013)
Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by 1H nuclear magnetic resonance-based metabonomic profiles
Lin Zhang et al.
CLINICAL BIOCHEMISTRY (2012)
Bioinformatics Tools for Mass Spectroscopy-Based Metabolomic Data Processing and Analysis
Masahiro Sugimoto et al.
CURRENT BIOINFORMATICS (2012)
Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals
Marcia Irene Canto et al.
GASTROENTEROLOGY (2012)
Utility of Nuclear Magnetic Resonance Spectroscopy for Pancreatic Cancer Studies
Yasvir A. Tesiram et al.
PANCREAS (2012)
Monitoring of CA19-9 and SPan-1 can facilitate the earlier confirmation of progressing pancreatic cancer during chemotherapy
Koichiro Tsutsumi et al.
PANCREATOLOGY (2012)
Multimodality imaging of pancreatic ductal adenocarcinoma: a review of the literature
Shailesh V. Shrikhande et al.
HPB (2012)
Metabolomic Profiling of Serum from Human Pancreatic Cancer Patients Using 1H NMR Spectroscopy and Principal Component Analysis
Dong OuYang et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2011)
Feasibility of Identifying Pancreatic Cancer Based on Serum Metabolomics
Oliver F. Bathe et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
CURRENT STATUS OF DIAGNOSTIC ENDOSCOPIC ULTRASONOGRAPHY IN THE EVALUATION OF PANCREATIC MASS LESIONS
Takao Itoi et al.
DIGESTIVE ENDOSCOPY (2011)
Metabolomic profiling of human plasma in pancreatic cancer using pressurized capillary electrochromatography
Huiping Zhang et al.
ELECTROPHORESIS (2011)
Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease
Tomoyoshi Soga et al.
JOURNAL OF HEPATOLOGY (2011)
A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer
He Wen et al.
JOURNAL OF HEPATOLOGY (2010)
Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles
Masahiro Sugimoto et al.
METABOLOMICS (2010)
Serum metabolomics as a novel diagnostic approach for pancreatic cancer
Shin Nishiumi et al.
METABOLOMICS (2010)
Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer
Shiro Urayama et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2010)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Metabolic phenotyping in health and disease
Elaine Holmes et al.
CELL (2008)
Discrimination of metabolic profiles of pancreatic cancer from chronic pancreatitis by high-resolution magic angle spinning 1H nuclear magnetic resonance and principal components analysis
Fang Fang et al.
CANCER SCIENCE (2007)
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
K. S. Goonetilleke et al.
EJSO (2007)
Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption
Tomoyoshi Soga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer
XG Ni et al.
EJSO (2005)
Statistical significance for genomewide studies
JD Storey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Worldwide trends in mortality from biliary tract malignancies
T Patel
BMC CANCER (2002)
Early detection of pancreatic carcinoma
C Rosty et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2002)
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States
T Patel
HEPATOLOGY (2001)
分享论文
